FDCDDQ
INFI

Federation des caisses Desjardins du Quebec’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-17,433
Closed -$27.4K – 2182
2017
Q2 		$27.4K Hold
17,433
– – ﹤0.01% 1518
2017
Q1 		$56.3K Buy
+17,433
New +$42.9K ﹤0.01% 1124

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's INFI Position: Q3 2017 in Review

Federation des caisses Desjardins du Quebec sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2017, closing a stake of 17,433 shares — an estimated $27.4K sold.

Federation des caisses Desjardins du Quebec first reported a position in INFI in Q1 2017 and held it in 2 quarters. The position peaked at $56.3K in Q1 2017. 63 funds tracked by Wall St. Rank hold INFI as of Q3 2017.

  • Federation des caisses Desjardins du Quebec reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 17,433 Infinity Pharmaceuticals, Inc. shares in Q3 2017, an estimated $27.4K.
  • Federation des caisses Desjardins du Quebec first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2017 and held it in 2 quarters.
  • Federation des caisses Desjardins du Quebec's Infinity Pharmaceuticals, Inc. position peaked at $56.3K in Q1 2017.
  • 63 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2017.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2017, filed 30 Aug 2024.